2,974
Participants
Start Date
July 27, 2021
Primary Completion Date
October 18, 2024
Study Completion Date
October 18, 2024
Data collection
"Data collection~* on the effect of a bundle of measures on the proportion of females being screened for cervical cancer in the Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) comparing the time period before implementation (01/2017-01/2020) and after implementation (02/2020-06/2022)~* on the performance of three novel tests as triage tool in the screening algorithm, QG-MPH, Prevo-check® and PT Monitor®"
Saint Francis Referral Hospital, Ifakara Health Institute (IHI, United Republic of Tanzania), Ifakara
Krebsforschung Schweiz, Bern, Switzerland
OTHER
Abviris Deutschland GmbH
UNKNOWN
Charité-University Medicine (Berlin, Germany)
UNKNOWN
Swiss Tropical and Public Health Institute (Switzerland)
UNKNOWN
University Hospital, Basel, Switzerland
OTHER